Strensiq (Asfotase Alfa Vials) 40mg/ml 18mg/0.45ml

Strensiq (Asfotase Alfa) is an enzyme replacement therapy for metabolic bone disorders. Administered via injection, it supports bone health and mineralization. Store refrigerated between 2-8°C. Consult a healthcare provider for suitability.

Strength

40mg/ml 18mg/0.45ml

Pack Size

12s

Storage

2-8ºC

Manufacturer / TM Owner

Alexion

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Strensiq (Asfotase Alfa) is used to treat perinatal, infantile, and juvenile-onset hypophosphatasia (HPP), a rare metabolic bone disorder. It helps improve bone mineralization and growth in patients with confirmed enzyme deficiency. This therapy targets the underlying cause of HPP by replacing deficient tissue-nonspecific alkaline phosphatase. It is prescribed for long-term management under medical supervision.

Side Effects

Strensiq works by providing the missing enzyme to help the body properly mineralize bones. Patients may experience improved skeletal strength and reduced bone pain over time. Some individuals notice better mobility and growth milestones with consistent use. The effects vary based on the severity of the condition and individual response.

Precautions & Warnings

Strensiq should be handled with care to avoid contamination or improper dosing. Always check the solution for particles or discoloration before use. Keep vials refrigerated and protect from light. Discard any unused portion after use. Patients should follow their healthcare provider’s instructions for storage and administration.

Avoid Interactions

Limited data exists on interactions with Strensiq. However, caution is advised when combining with other medications that affect bone metabolism. Avoid mixing with other injectable drugs in the same vial. Patients should inform their doctor about all current medications, including supplements, before starting Strensiq.

References

Frequently Asked Questions

Strensiq is used to treat hypophosphatasia (HPP), a rare bone disorder caused by enzyme deficiency.

Strensiq is given as an injection under the skin, typically by a healthcare professional or caregiver.

No, Strensiq must be refrigerated between 2-8°C and protected from light.

Common effects may include injection site reactions, nausea, or headache. Report persistent issues to a doctor.

Strensiq may be available through licensed pharmacies with a prescription. Consult a healthcare provider for options.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.